Literature DB >> 25406330

[ESC/EACTS guidelines on myocardial revascularization : Amendments 2014].

H Nef1, M Renker, C W Hamm.   

Abstract

One of the most important treatment principles in interventional cardiology relies on myocardial revascularization by percutaneous coronary intervention (PCI) or surgical placement of coronary artery bypass grafts (CABG). However, in order to apply these principles effectively, it is important to identify patients who require revascularization. Consequently, the appropriate method has to be selected to effectively restore blood flow. Patients will only benefit from the interventional or surgical procedures when those revascularization measures that can cause more harm than good are avoided. In the new European Society of Cardiology and European Association for Cardio-Thoracic Surgery (ESC/EACTS) guidelines on myocardial revascularization some new aspects will be addressed.

Entities:  

Mesh:

Year:  2014        PMID: 25406330     DOI: 10.1007/s00059-014-4180-4

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  58 in total

1.  EuroSCORE II.

Authors:  Samer A M Nashef; François Roques; Linda D Sharples; Johan Nilsson; Christopher Smith; Antony R Goldstone; Ulf Lockowandt
Journal:  Eur J Cardiothorac Surg       Date:  2012-02-29       Impact factor: 4.191

2.  Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes.

Authors:  Gilles Montalescot; Leonardo Bolognese; Dariusz Dudek; Patrick Goldstein; Christian Hamm; Jean-Francois Tanguay; Jurrien M ten Berg; Debra L Miller; Timothy M Costigan; Jochen Goedicke; Johanne Silvain; Paolo Angioli; Jacek Legutko; Margit Niethammer; Zuzana Motovska; Joseph A Jakubowski; Guillaume Cayla; Luigi Oltrona Visconti; Eric Vicaut; Petr Widimsky
Journal:  N Engl J Med       Date:  2013-09-01       Impact factor: 91.245

3.  The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery.

Authors:  David M Shahian; Sean M O'Brien; Giovanni Filardo; Victor A Ferraris; Constance K Haan; Jeffrey B Rich; Sharon-Lise T Normand; Elizabeth R DeLong; Cynthia M Shewan; Rachel S Dokholyan; Eric D Peterson; Fred H Edwards; Richard P Anderson
Journal:  Ann Thorac Surg       Date:  2009-07       Impact factor: 4.330

4.  Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.

Authors:  Fausto Feres; Ricardo A Costa; Alexandre Abizaid; Martin B Leon; J Antônio Marin-Neto; Roberto V Botelho; Spencer B King; Manuela Negoita; Minglei Liu; J Eduardo T de Paula; José A Mangione; George X Meireles; Hélio J Castello; Eduardo L Nicolela; Marco A Perin; Fernando S Devito; André Labrunie; Décio Salvadori; Marcos Gusmão; Rodolfo Staico; J Ribamar Costa; Juliana P de Castro; Andrea S Abizaid; Deepak L Bhatt
Journal:  JAMA       Date:  2013-12-18       Impact factor: 56.272

5.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

6.  Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study).

Authors:  David M Shahian; Sean M O'Brien; Shubin Sheng; Frederick L Grover; John E Mayer; Jeffrey P Jacobs; Jocelyn M Weiss; Elizabeth R Delong; Eric D Peterson; William S Weintraub; Maria V Grau-Sepulveda; Lloyd W Klein; Richard E Shaw; Kirk N Garratt; Issam D Moussa; Cynthia M Shewan; George D Dangas; Fred H Edwards
Journal:  Circulation       Date:  2012-02-23       Impact factor: 29.690

7.  Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.

Authors:  Akhil Kapur; Roger J Hall; Iqbal S Malik; Ayesha C Qureshi; Jeremy Butts; Mark de Belder; Andreas Baumbach; Gianni Angelini; Adam de Belder; Keith G Oldroyd; Marcus Flather; Michael Roughton; Petros Nihoyannopoulos; Jens Peder Bagger; Kenneth Morgan; Kevin J Beatt
Journal:  J Am Coll Cardiol       Date:  2010-02-02       Impact factor: 24.094

Review 8.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

9.  Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation.

Authors:  Sigmund Silber; Ajay J Kirtane; Jorge A Belardi; Minglei Liu; Sandeep Brar; Martin Rothman; Stephan Windecker
Journal:  Eur Heart J       Date:  2014-02-07       Impact factor: 29.983

10.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.

Authors:  S Yusuf; D Zucker; P Peduzzi; L D Fisher; T Takaro; J W Kennedy; K Davis; T Killip; E Passamani; R Norris
Journal:  Lancet       Date:  1994-08-27       Impact factor: 79.321

View more
  2 in total

Review 1.  [Instantaneous wave-free ratio (iFR®) in patients with coronary artery disease].

Authors:  S Baumann; A C Schaefer; A Hohneck; K Mueller; T Becher; M Behnes; M Renker; M Borggrefe; I Akin; D Lossnitzer
Journal:  Herz       Date:  2017-08-23       Impact factor: 1.443

Review 2.  [Computed tomography in patients with chronic stable angina : Fractional flow reserve measurement].

Authors:  M Renker; U J Schoepf; T Becher; N Krampulz; W Kim; A Rolf; H Möllmann; C W Hamm; T Henzler; M Borggrefe; I Akin; S Baumann
Journal:  Herz       Date:  2016-06-02       Impact factor: 1.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.